Physician profile
Gary E Okuley
NPI 1144211558
$3,130.88
in general payments reported to CMS, 2019-2025
39 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $217 · 2021: $615 · 2022: $833 · 2023: $685 · 2024: $102 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $552.04 | 2021-2025 | |
| Pfizer INC. | $329.55 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $224.73 | 2019-2023 | Livalo, Seglentis |
| Novo Nordisk INC | $208.24 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals Lp | $179.79 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $157.97 | 2019-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Otsuka America Pharmaceutical, INC. | $144.22 | 2021-2023 | Rexulti |
| Novartis Pharmaceuticals Corporation | $139.23 | 2019-2022 | |
| Amgen INC. | $131.69 | 2019-2025 | Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $107.04 | 2021-2023 | |
| Abbott Laboratories | $89.64 | 2021-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $84.23 | 2021-2022 | |
| Dexcom, INC. | $83.27 | 2021-2024 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $80.61 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.78 | 2019-2023 | Ofev |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Okuley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.